Partnership for Safe Medicines India

Formed: Decemer 2010

Website: www.safemedicinesindia.in

Media contact (India): Toll Free Helpline:1800-11-4424

Media contact (US): Teresa Schofield, teresa@safemedicines.org, +1.202.347.7947

Media fact sheet: About PSM India [PDF]

Media coverage:

• Partnership For Safe Medicines Launches India Initiative,
  The Business Standard
• Health Group to Protect Consumers Against Fake Drugs,
  Press Trust of India
• Partnership for Safe Medicines begins India Initiative,
  Indian Express
• Consumers Get Anti-Fake Drugs Watchdog,
  The Financial Express
• Health Group to Protect Consumers Against Fake Drugs,
  The Wall Street Journal
• Partnership for Safe Medicines (PSM) Announces Major International Expansion with Launch of (PSM) India, Media Info World
• Stakeholders Join Together to Launch Partnership for Safe Medicines to Fight Spurious Drugs, Pharmabiz.com
• In Turnabout, India to Send Inspectors Overseas, Fierce Pharma
• Partnership For Safe Medicines (PSM) Announces Major International Expansion with Launch of India Initiative, Healthcare Packaging
• PSM Forms Affiliate to Tackle Counterfeits in India, In-Pharma Technologist
• Partnership for Safe Medicines launches Indian Initiative, Securing Pharma
• US Drug Agency seeks CBI help for Counterfeit Info, The Financial Express
• Mumbai Sandhya, print only
• Mumbai Mitra, print only

Mission: To serve as a coalition of organizations and individuals seeking to protect consumers from spurious or contraband medicines in the country.

1. To raise public awareness of the harms to patient safely caused by spurious drugs
2. To inform consumers and distributors of medicines in the community the existence and extent of spurious drug problem
3. To work collaboratively with the medical community
4. To educate Indian consumers on the importance of drug quality, how to identify suspected spurious drugs, and what actions to take when encounter a suspected case
5. To educate community healthcare practitioners in drugstores and health centers on the problem of spurious drugs and what role they can play to lessen the problem

Initial core group members:

1. Mr Ashok Kumar, 47, New Moti Bagh, New Delhi-110023
2. Dr. Meera Mitra, Governing Council Member, Cell for Consumer Education and Advocacy, Greater Kailash Enclave I, New Delhi 110048
3. Ms. Reena George, Cankids, Sector 14, Noida
4. Dr Manisha K Bhatla, Escorts Heart Institute & Research Centre, Okhla Road, New Delhi – 110 025
5. Dr. Prafull D. Sheth, Vice President, International Pharmaceutical Federation, E-256, Greater Kailash I, New Delhi -110048
6. Mr Bejon Misra, Founder Trustee, Consumer Online Foundation, D-14, 1st Floor, Greater Kailash Enclave II, New Delhi – 110 048
7. Mr. S., Krishnan, Chairman, Healthy You Foundation, E-212, Anand Lok, Mayur Vihar-I, Delhi – 110 091
8. Mr. Brijesh Regal, Chief Executive Officer, Apothecaries Clinical Research, 579, Devli, East Sainik Farms, New Delhi – 110 062
9. Dr. Vinay Agarwal, President Elect, Indian Medical Association, IMA House, Indraprastha Marg, New Delhi – 110 002
10. Ms. Vandana Saxena, Vice President, Consumers’ Forum, 228, Sidhartha Enclave, New Delhi – 110 014
11. Mr. A. K Jain, Principal Advisor, Quality Council of India, 2ndfloor,  Institution of Engineers Building, Bahadurshah Zafar Marg, New Delhi – 110 002
12. Dr Rashmi Kulshrestha, Regulatory Consultant, Regulatory Wisdom, 113-114, Vardhman Grand Market, Sector 3,  Dwarka, New Delhi – 110 078
13. Dr Raja Smarta, Managing Director, Interlink Marketing Consultancy Pvt.Ltd., 3A, Central Plaza, 166 CST Road, Kalina, Santacruz (East), Mumbai – 400 098
14. Mr. T. K. Govindan, A/62 Double Storey, Kalkaji Main Road, New Delhi 110019.

View event photos on Flickr.